> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pharm D Solutions Recalls Compounded Drugs
- URL: https://www.fdaweb.com/pharm-d-solutions-recalls-compounded-drugs/
- Published: 2019-05-28T12:00:00.000Z
- Updated: 2026-09-15T01:29:02.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144198

Pharm D Solutions has recalled all sterile compounded drug products due to FDA inspection concerns that practices at the pharmacy have the potential to pose a risk of contamination to products that are intended to be sterile. “Administration of a non-sterile product that is intended to be sterile by subcutaneous, intramuscular, intravenous or ocular routes of administration may result in serious injury or death,” a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pharm-d-solutions-llc-issues-voluntary-nationwide-recall-all-sterile-compounded-drugs-due-potential-0?ref=fdaweb.com) says. To date, company says it is not aware of any adverse events related to the recall. The recall covers all compounded sterile drug products, within expiry, that were dispensed from 10/24/2018 to 5/21/2019.